An Investigation on a Novel Anti-tumor Fusion Peptide of FSH(33-53)-IIKK

A novel fusion peptide FSH(33-53)-IIKK was designed and expected to combine the follicle stimulating hormone receptor (FSHR) targeting and tumor toxicity. In vitro and in vivo study showed the anti-tumor activity of FSH(33-53)-IIKK was enhanced compared to that of IIKK only. FSH(33-53)-IIKK could in...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Cancer
Prif Awduron: Yang, Runlin, Liu, Ping, Pan, Donghui, zhang, Pengjun, Bai, Zhicheng, Xu, Yuping, Wang, Lizhen, Yan, Junjie, Yan, Yongjun, Liu, Xingdang, Yang, Min
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Ivyspring International Publisher 2016
Pynciau:
Research Paper
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910594/
https://ncbi.nlm.nih.gov/pubmed/27313792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.14425
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg